AirSculpt TechnologiesAIRS +2.49%73 Buyback Yield % is -10.46 as of Jul. 03, 2026. GuruFocus rates AIRS with a GF Score™ of 73/100 and a GF Value™ of $3.92 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 272 Healthcare Providers & Services companies, AirSculpt Technologies ranks worse than 76.84% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
AirSculpt Technologies Buyback Yield % Related Terms
AirSculpt Technologies Buyback Yield % Historical Data
* Premium members only.
The historical data trend for AirSculpt Technologies's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIRS vs AUNA, CCRN, SRTA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, AirSculpt Technologies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AirSculpt Technologies Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where AirSculpt Technologies's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AirSculpt Technologies (AIRS) has a Buyback Yield % of -10.46 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on AirSculpt Technologies and its competitors. According to the industry distribution chart, AirSculpt Technologies ranks #209 out of 272 companies in the Healthcare Providers & Services industry, placing it in the top 76.8%.
Is AirSculpt Technologies' Buyback Yield % too high?
AirSculpt Technologies' current Buyback Yield % is -10.46. Based on the distribution chart, AirSculpt Technologies ranks #209 out of 272 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, AirSculpt Technologies has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' Buyback Yield % compare to AUNA and CCRN?
According to the Healthcare Providers & Services industry distribution chart, AirSculpt Technologies ranks #209 out of 272 companies for Buyback Yield %. This places AirSculpt Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on AirSculpt Technologies and its competitors. AirSculpt Technologies's current Buyback Yield % is -10.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.92, compared to a current price of $4.52 — trading 15.3% above its estimated fair value. The current Buyback Yield % is -10.46. AirSculpt Technologies' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current Buyback Yield % is -10.46 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AirSculpt Technologies (AIRS) Overvalued in 2026?
Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued.
The current stock price of $4.52 is trading 15.3% above its estimated GF Value™ of $3.92.
GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.
Key valuation signals for AIRS:
Buyback Yield %: -10.46
GF Value™: $3.92 vs. price of $4.52 (15.3% above fair value)
No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
73GF Score
Get the complete analysis for AIRS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRS has been successfully added to your 
